SCHEMBL7918689

SCHEMBL7918689

C=C(O)c1ccc2cccc(-c3ccccn3)c2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.45
TP53 P04637 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MAPK1 P28482 2/20 0.45
NPC1 O15118 2/20 0.45
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
HPGD P15428 2/20 0.45
HSD17B10 Q99714 1/20 0.45
HTR2C P28335 2/20 0.42
ADORA3 P0DMS8 4/20 0.41
TDP1 Q9NUW8 2/20 0.40
LMNA P02545 1/20 0.40
ALPL P05186 1/20 0.40
HSP90AA1 P07900 1/20 0.40
ALPI P09923 1/20 0.40
ALPG P10696 1/20 0.40
ALOX15 P16050 1/20 0.40
CCR1 P32246 1/20 0.40
HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16502733 0.86 KDM4E (0.55) KDM4ETP53SMN1; SMN2MAPK1NPC1
SCHEMBL16503496 0.83 HTR2C (0.43) KDM4ETP53SMN1; SMN2MAPK1NPC1
SCHEMBL7920176 0.80 CCR1 (0.46) KDM4ETP53SMN1; SMN2ALDH1A1MAPT
SCHEMBL7917427 0.79 F2 (0.41) KDM4ESMN1; SMN2MAPK1NPC1ALDH1A1
SCHEMBL7915349 0.79 ALOX15 (0.52) KDM4ETP53SMN1; SMN2MAPK1NPC1
SCHEMBL7920129 0.79 TNF (0.45) KDM4ETP53SMN1; SMN2MAPK1ALDH1A1
SCHEMBL28065836 0.77 CCR1 (0.51) KDM4ETP53SMN1; SMN2MAPK1NPC1
SCHEMBL16503471 0.77 DOT1L (0.39) KDM4ETP53SMN1; SMN2ALDH1A1MAPT
SCHEMBL16502849 0.77 HTR5A (0.48) HTR2CPLAU
SCHEMBL12626761 0.76 KDM4E (0.52) KDM4ETP53SMN1; SMN2MAPK1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010090304-A1 ACYLGUANIDINE DERIVATIVE アステラス製薬株式会社 (JP) 2010-08-12 WO disclosed